Skip to main content

-

RYC-2012-12068

•
Funding agency name Ministerio de Ciencia e Innovación
Funding agency acronym MICINN
Program Programa Nacional de Contratación e Incorporación de RRHH
Subprogram Subprograma Ramón y Cajal (RYC)
Call Ramón y Cajal
Call year 2012
State Plan 2008-2011 Plan Nacional de Investigación Científica, Desarrollo e Innovación Tecnológica
Management unit Secretaría de Estado de Educación, Formación Profesional y Universidades
Beneficiary centre UNIVERSIDAD DE ZARAGOZA

Resultados relacionados

Resultados totales (Incluyendo duplicados): 11
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

The extent of protein hydration dictates the preference for heterogeneous or homogeneous nucleation generating either parallel or antiparallel β-sheet α-synuclein aggregates

  • Camino, José D.
  • Gracia, Pablo
  • Chen, S.W.
  • Sot, Jesús
  • Arada, Igor de la
  • Sebastián, Víctor
  • Arrondo, José Luis R.
  • Goñi, Félix M.
  • Dobson, Christopher M.
  • Cremades, Nunilo
13 pags., 8 figs., α-Synuclein amyloid self-assembly is the hallmark of a number of neurodegenerative disorders, including Parkinson's disease, although there is still very limited understanding about the factors and mechanisms that trigger this process. Primary nucleation has been observed to be initiated in vitro at hydrophobic/hydrophilic interfaces by heterogeneous nucleation generating parallel β-sheet aggregates, although no such interfaces have yet been identified in vivo. In this work, we have discovered that α-synuclein can self-assemble into amyloid aggregates by homogeneous nucleation, without the need of an active surface, and with a preference for an antiparallel β-sheet arrangement. This particular structure has been previously proposed to be distinctive of stable toxic oligomers and we here demonstrate that it indeed represents the most stable structure of the preferred amyloid pathway triggered by homogeneous nucleation under limited hydration conditions, including those encountered inside α-synuclein droplets generated by liquid-liquid phase separation. In addition, our results highlight the key role that water plays not only in modulating the transition free energy of amyloid nucleation, and thus governing the initiation of the process, but also in dictating the type of preferred primary nucleation and the type of amyloid polymorph generated depending on the extent of protein hydration. These findings are particularly relevant in the context of in vivo α-synuclein aggregation where the protein can encounter a variety of hydration conditions in different cellular microenvironments, including the vicinity of lipid membranes or the interior of membraneless compartments, which could lead to the formation of remarkably different amyloid polymorphs by either heterogeneous or homogeneous nucleation., This work was supported by MINECO (RYC-2012-12068, NC), MINECO/FEDER, EU (BFU2015-64119-P, NC), MICIU/FEDER, EU (PGC2018-096335-B-100, NC), MICIU/FEDER, EU (RTI2018- 099019-A-I00, VS), MCI/AEI/FEDER, UE (PGC2018-099857-BI00, FMG) and Basque Government (IT1264-19, FMG and IT1196-19, JLRA), and Fundacion Biofısica Bizkaia and the Basque Excellence Research Centre (BERC) program of the Basque Government (FMG, JLRA). We thank the Proteomics Unit of Servicios Cientifico Teecnicos del CIBA (IACS-Universidad de Zaragoza), Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Structural basis of membrane disruption and cellular toxicity by a-synuclein oligomers

  • Fusco, Giuliana
  • Chen, Serene W.
  • Williamson, Philip T. F.
  • Cascella, Roberta
  • Perni, Michele
  • Jarvis, James A.
  • Cecchi, Cristina
  • Vendruscolo, Michele
  • Chiti, Fabrizio
  • Cremades, Nunilo
  • Ying, Liming
  • Dobson, Christopher M.
  • De Simone, Alfonso
5 pags, 3 figs, Oligomeric species populated during the aggregation process of a-synuclein have been linked to neuronal impairment in Parkinson's disease and related neurodegenerative disorders. By using solution and solid-state nuclear magnetic resonance techniques in conjunction with other structural methods, we identified the fundamental characteristics that enable toxic a-synuclein oligomers to perturb biological membranes and disrupt cellular function; these include a highly lipophilic element that promotes strong membrane interactions and a structured region that inserts into lipid bilayers and disrupts their integrity. In support of these conclusions, mutations that target the region that promotes strong membrane interactions by a-synuclein oligomers suppressed their toxicity in neuroblastoma cells and primary cortical neurons., This research was supported by Parkinson's UK (G-1508 to G.F., M.V., C.M.D., and A.D.); the UK Medical Research Council (MR/N000676/1 to G.F., M.V. C.M.D., and A.D.); the Wellcome Trust (104933/2/14E to kD.): the Leverhulme Trust (RPG-2015-350 to A.D. and RPG-2015-345 to L.Y.); the British Heart Foundation (PG/14/93/31237 to A.D. and PG/11/81/29130 to L.Y.); the UK Biotechnology and Biological Sciences Research Council (BB/M023923/1 to A.D. and BB/G00594X/1 to L.Y.); the Agency of Science, Technology and Research of Singapore (to S.W.C.); the Ministry of Economy, Industry, and Competitiveness of Spain (MINECO RYC-2012-12068 and MINECO/FEDER EU BEU2015-64119-P to N.C.); the Regione Toscana (SUPREMAL to E.C., C.C., and R.C); the University of Florence (Eondi di Ateneo to E.C. and. C.C); and the Centre for Misfolding Diseases of the University of Cambridge. The data supporting the findings of this study are available within the article and supplementary materials., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

All-or-none amyloid disassembly via chaperone-triggered fibril unzipping favors clearance of α-synuclein toxic species

  • Franco, Aitor
  • Gracia, Pablo
  • Colom, Adai
  • Camino, José D.
  • Fernández-Higuero, José Ángel
  • Orozco, Natalia
  • Dulebo, Alexander
  • Saiz, Leonor
  • Cremades, Nunilo
  • Vilar, Jose M. G.
  • Prado, Adelina
  • Muga, Arturo
11 pags., 5 figs., α-synuclein aggregation is present in Parkinson’s disease and other neuropathologies. Among the assemblies that populate the amyloid formation process, oligomers and short fibrils are the most cytotoxic. The human Hsc70-based disaggregase system can resolve α-synuclein fibrils, but its ability to target other toxic assemblies has not been studied. Here, we show that this chaperone system preferentially dis-aggregates toxic oligomers and short fibrils, while its activity against large, less toxic amyloids is severely impaired. Biochemical and kinetic characterization of the disassembly process reveals that this behavior is the result of an all-or-none abrupt solubilization of individual aggregates. High-speed atomic force microscopy explicitly shows that disassembly starts with the destabilization of the tips and rapidly progresses to completion through protofilament unzipping and depolymerization without accumulation of harmful oligomeric intermediates. Our data provide molecular insights into the selective processing of toxic amyloids, which is critical to identify potential therapeutic targets against increasingly prevalent neurodegenerative disorders., This work was supported by MCI/AEI/FEDER, UE (Grants PGC2018-101282-B-I00 to J.M.G.V, PGC2018-096335-B-100 to N.C., and PID2019-111068GB-I00 to A.M.), MINECO/FEDER, UE (Grants RYC-2012-12068 and BFU2015-64119-P to N.C.), and by the Basque Government (Grant IT1201-19 to A.M. and A.P.). A.C. also acknowledges funding from MCIU, PID2019-111096GA-I00; MCIU/AEI/FEDER MINECOG19/P66 , RYC2018-024686-I, and Basque Government T1270-19. L.S. acknowledges support from the University of California, Davis. A.F. thanks a predoctoral fellowship from the Basque Government. The technical and human support provided by the microscopy service of SGIker (UPV/EHU/ERDF, EU) is acknowledged. We thank J. M. Valpuesta and J. Cuellar for the visualization of α-syn oligomers by EM
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

All-or-none amyloid disassembly via chaperone-triggered fibril unzipping favors clearance of α-synuclein toxic species

  • Franco, Aitor
  • Gracia, Pablo
  • Colom, Adai
  • Camino, José D.
  • Fernández-Higuero, José Ángel
  • Orozco, Natalia
  • Dulebo, Alexander
  • Dulebo, Alexander
  • Saiz, Leonor
  • Cremades, Nunilo
  • Vilar, Jose M. G.
  • Prado, Adelina
  • Muga, Arturo
11 pags., 5 figs., α-synuclein aggregation is present in Parkinson’s disease and other neuropathologies. Among the assemblies that populate the amyloid formation process, oligomers and short fibrils are the most cytotoxic. The human Hsc70-based disaggregase system can resolve α-synuclein fibrils, but its ability to target other toxic assemblies has not been studied. Here, we show that this chaperone system preferentially dis-aggregates toxic oligomers and short fibrils, while its activity against large, less toxic amyloids is severely impaired. Biochemical and kinetic characterization of the disassembly process reveals that this behavior is the result of an all-or-none abrupt solubilization of individual aggregates. High-speed atomic force microscopy explicitly shows that disassembly starts with the destabilization of the tips and rapidly progresses to completion through protofilament unzipping and depolymerization without accumulation of harmful oligomeric intermediates. Our data provide molecular insights into the selective processing of toxic amyloids, which is critical to identify potential therapeutic targets against increasingly prevalent neurodegenerative disorders., This work was supported by MCI/AEI/FEDER, UE (Grants PGC2018-101282-B-I00 to J.M.G.V, PGC2018-096335-B-100 to N.C., and PID2019-111068GB-I00 to A.M.), MINECO/FEDER, UE (Grants RYC-2012-12068 and BFU2015-64119-P to N.C.), and by the Basque Government (Grant IT1201-19 to A.M. and A.P.). A.C. also acknowledges funding from MCIU, PID2019-111096GA-I00; MCIU/AEI/FEDER MINECOG19/P66 , RYC2018-024686-I, and Basque Government T1270-19. L.S. acknowledges support from the University of California, Davis. A.F. thanks a predoctoral fellowship from the Basque Government. The technical and human support provided by the microscopy service of SGIker (UPV/EHU/ERDF, EU) is acknowledged. We thank J. M. Valpuesta and J. Cuellar for the visualization of α-syn oligomers by EM
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

All-or-none amyloid disassembly via chaperone-triggered fibril unzipping favors clearance of α-synuclein toxic species

  • Franco, Aitor
  • Gracia, Pablo
  • Colom, Adai
  • Camino, José D.
  • Fernández-Higuero, José Ángel
  • Orozco, Natalia
  • Dulebo, Alexander
  • Dulebo, Alexander
  • Saiz, Leonor
  • Cremades, Nunilo
  • Vilar, Jose M. G.
  • Prado, Adelina
  • Muga, Arturo
11 pags., 5 figs., α-synuclein aggregation is present in Parkinson’s disease and other neuropathologies. Among the assemblies that populate the amyloid formation process, oligomers and short fibrils are the most cytotoxic. The human Hsc70-based disaggregase system can resolve α-synuclein fibrils, but its ability to target other toxic assemblies has not been studied. Here, we show that this chaperone system preferentially dis-aggregates toxic oligomers and short fibrils, while its activity against large, less toxic amyloids is severely impaired. Biochemical and kinetic characterization of the disassembly process reveals that this behavior is the result of an all-or-none abrupt solubilization of individual aggregates. High-speed atomic force microscopy explicitly shows that disassembly starts with the destabilization of the tips and rapidly progresses to completion through protofilament unzipping and depolymerization without accumulation of harmful oligomeric intermediates. Our data provide molecular insights into the selective processing of toxic amyloids, which is critical to identify potential therapeutic targets against increasingly prevalent neurodegenerative disorders., This work was supported by MCI/AEI/FEDER, UE (Grants PGC2018-101282-B-I00 to J.M.G.V, PGC2018-096335-B-100 to N.C., and PID2019-111068GB-I00 to A.M.), MINECO/FEDER, UE (Grants RYC-2012-12068 and BFU2015-64119-P to N.C.), and by the Basque Government (Grant IT1201-19 to A.M. and A.P.). A.C. also acknowledges funding from MCIU, PID2019-111096GA-I00; MCIU/AEI/FEDER MINECOG19/P66 , RYC2018-024686-I, and Basque Government T1270-19. L.S. acknowledges support from the University of California, Davis. A.F. thanks a predoctoral fellowship from the Basque Government. The technical and human support provided by the microscopy service of SGIker (UPV/EHU/ERDF, EU) is acknowledged. We thank J. M. Valpuesta and J. Cuellar for the visualization of α-syn oligomers by EM
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

A natural product inhibits the initiation of a-synuclein aggregation & suppresses its toxicity

  • Perni, M.
  • Galvagnion, C.
  • Maltsev, A.
  • Meisl, G.
  • Müller, M.B.D.
  • Challa, P.K.
  • Kirkegaard, J.B.
  • Flagmeier, P.
  • Cohen, S.I.A.
  • Cascella, R.
  • Chen, S.W.
  • Limboker, R.
  • Sormanni, P.
  • Heller, G.T.
  • Aprile, F.A.
  • Cremades, N.
  • Cecchi, C.
  • Chiti, F.
  • Nollen, E.A.A.
  • Knowles, T.P.J.
  • Vendruscolo, M.
  • Bax, A.
  • Zasloff, M.
  • Dobson, C.M.
The self-Assembly of a-synuclein is closely associated with Parkinson''s disease and related syndromes. We show that squalamine, a natural product with known anticancer and antiviral activity, dramatically affects a-synuclein aggregation in vitro and in vivo. We elucidate the mechanism of action of squalamine by investigating its interaction with lipid vesicles, which are known to stimulate nucleation, and find that this compound displaces a-synuclein from the surfaces of such vesicles, thereby blocking the first steps in its aggregation process. We also show that squalamine almost completely suppresses the toxicity of a-synuclein oligomers in human neuroblastoma cells by inhibiting their interactions with lipid membranes. We further examine the effects of squalamine in a Caenorhabditis elegans strain overexpressing a-synuclein, observing a dramatic reduction of a-synuclein aggregation and an almost complete elimination of muscle paralysis. These findings suggest that squalamine could be a means of therapeutic intervention in Parkinson''s disease and related conditions.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

The extent of protein hydration dictates the preference for heterogeneous or homogeneous nucleation generating either parallel or antiparallel ß-sheet a-synuclein aggregates

  • Camino, J.D.
  • Gracia, P.
  • Chen, S.W.
  • Sot, J.
  • De La Arada, I.
  • Sebastián, V.
  • Arrondo, J.L.R.
  • Goñi, F.M.
  • Dobson, C.M.
  • Cremades, N.
a-Synuclein amyloid self-assembly is the hallmark of a number of neurodegenerative disorders, including Parkinson 's disease, although there is still very limited understanding about the factors and mechanisms that trigger this process. Primary nucleation has been observed to be initiated in vitro at hydrophobic/hydrophilic interfaces by heterogeneous nucleation generating parallel ß-sheet aggregates, although no such interfaces have yet been identified in vivo. In this work, we have discovered that a-synuclein can self-assemble into amyloid aggregates by homogeneous nucleation, without the need of an active surface, and with a preference for an antiparallel ß-sheet arrangement. This particular structure has been previously proposed to be distinctive of stable toxic oligomers and we here demonstrate that it indeed represents the most stable structure of the preferred amyloid pathway triggered by homogeneous nucleation under limited hydration conditions, including those encountered inside a-synuclein droplets generated by liquid-liquid phase separation. In addition, our results highlight the key role that water plays not only in modulating the transition free energy of amyloid nucleation, and thus governing the initiation of the process, but also in dictating the type of preferred primary nucleation and the type of amyloid polymorph generated depending on the extent of protein hydration. These findings are particularly relevant in the context of in vivo a-synuclein aggregation where the protein can encounter a variety of hydration conditions in different cellular microenvironments, including the vicinity of lipid membranes or the interior of membraneless compartments, which could lead to the formation of remarkably different amyloid polymorphs by either heterogeneous or homogeneous nucleation.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

The role of water in the primary nucleation of protein amyloid aggregation

  • Camino, J.D.
  • Gracia, P.
  • Cremades, N.
The understanding of the complex conformational landscape of amyloid aggregation and its modulation by relevant physicochemical and cellular factors is a prerequisite for elucidating some of the molecular basis of pathology in amyloid related diseases, and for developing and evaluating effective disease-specific therapeutics to reduce or eliminate the underlying sources of toxicity in these diseases. Interactions of proteins with solvating water have been long considered to be fundamental in mediating their function and folding; however, the relevance of water in the process of protein amyloid aggregation has been largely overlooked. Here, we provide a perspective on the role water plays in triggering primary amyloid nucleation of intrinsically disordered proteins (IDPs) based on recent experimental evidences. The initiation of amyloid aggregation likely results from the synergistic effect between both protein intermolecular interactions and the properties of the water hydration layer of the protein surface. While the self-assembly of both hydrophobic and hydrophilic IDPs would be thermodynamically favoured due to large water entropy contributions, large desolvation energy barriers are expected, particularly for the nucleation of hydrophilic IDPs. Under highly hydrating conditions, primary nucleation is slow, being facilitated by the presence of nucleation-active surfaces (heterogeneous nucleation). Under conditions of poor water activity, such as those found in the interior of protein droplets generated by liquid-liquid phase separation, however, the desolvation energy barrier is significantly reduced, and nucleation can occur very rapidly in the bulk of the solution (homogeneous nucleation), giving rise to structurally distinct amyloid polymorphs. Water, therefore, plays a key role in modulating the transition free energy of amyloid nucleation, thus governing the initiation of the process, and dictating the type of preferred primary nucleation and the type of amyloid polymorph generated, which could vary depending on the particular microenvironment that the protein molecules encounter in the cell.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

a-Helical peptidic scaffolds to target a-synuclein toxic species with nanomolar affinity

  • Santos, J.
  • Gracia, P.
  • Navarro, S.
  • Peña-Díaz, S.
  • Pujols, J.
  • Cremades, N.
  • Pallarès, I.
  • Ventura, S.
a-Synuclein aggregation is a key driver of neurodegeneration in Parkinson’s disease and related syndromes. Accordingly, obtaining a molecule that targets a-synuclein toxic assemblies with high affinity is a long-pursued objective. Here, we exploit the biophysical properties of toxic oligomers and amyloid fibrils to identify a family of a-helical peptides that bind to these a-synuclein species with low nanomolar affinity, without interfering with the monomeric functional protein. This activity is translated into a high anti-aggregation potency and the ability to abrogate oligomer-induced cell damage. Using a structure-guided search we identify a human peptide expressed in the brain and the gastrointestinal tract with analogous binding, anti-aggregation, and detoxifying properties. The chemical entities we describe here may represent a therapeutic avenue for the synucleinopathies and are promising tools to assist diagnosis by discriminating between native and toxic a-synuclein species. © 2021, The Author(s).
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

The Pathological G51D Mutation in Alpha-Synuclein Oligomers Confers Distinct Structural Attributes and Cellular Toxicity

  • Xu, Catherine K.
  • Castellana-Cruz, Marta
  • Chen, Serene W.
  • Du, Zhen
  • Meisl, Georg
  • Levin, Aviad
  • Mannini, Benedetta
  • Itzhaki, Laura
  • Knowles, Tuomas P. J.
  • Dobson, Christopher
  • Cremades, Nunilo
  • Kumita, Janet R.
A wide variety of oligomeric structures are formed during the aggregation of proteins associated with neurodegenerative diseases. Such soluble oligomers are believed to be key toxic species in the related disorders; therefore, identification of the structural determinants of toxicity is of upmost importance. Here, we analysed toxic oligomers of α-synuclein and its pathological variants in order to identify structural features that could be related to toxicity and found a novel structural polymorphism within G51D oligomers. These G51D oligomers can adopt a variety of β-sheet-rich structures with differing degrees of α-helical content, and the helical structural content of these oligomers correlates with the level of induced cellular dysfunction in SH-SY5Y cells. This structure–function relationship observed in α-synuclein oligomers thus presents the α-helical structure as another potential structural determinant that may be linked with cellular toxicity in amyloid-related proteins.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

α-Helical peptidic scaffolds to target α-synuclein toxic species with nanomolar affinity

  • Santos Suárez, Jaime|||0000-0001-9045-7765
  • Gracia González, Pablo
  • Navarro, Susanna|||0000-0001-8160-9536
  • Peña Díaz, Samuel|||0000-0002-2902-823X
  • Pujols Pujol, Jordi|||0000-0001-9424-5866
  • Cremades, Nunilo|||0000-0002-9138-6687
  • Pallarès i Goitiz, Irantzu|||0000-0002-8205-2060
  • Ventura, Salvador|||0000-0002-9652-6351
α-Synuclein aggregation is a key driver of neurodegeneration in Parkinson's disease and related syndromes. Accordingly, obtaining a molecule that targets α-synuclein toxic assemblies with high affinity is a long-pursued objective. Here, we exploit the biophysical properties of toxic oligomers and amyloid fibrils to identify a family of α-helical peptides that bind to these α-synuclein species with low nanomolar affinity, without interfering with the monomeric functional protein. This activity is translated into a high anti-aggregation potency and the ability to abrogate oligomer-induced cell damage. Using a structure-guided search we identify a human peptide expressed in the brain and the gastrointestinal tract with analogous binding, anti-aggregation, and detoxifying properties. The chemical entities we describe here may represent a therapeutic avenue for the synucleinopathies and are promising tools to assist diagnosis by discriminating between native and toxic α-synuclein species. α-Synuclein (αS) aggregation is a driver of several neurodegenerative disorders. Here, the authors identify a class of peptides that bind toxic αS oligomers and amyloid fibrils but not monomeric functional protein, and prevent further αS aggregation and associated cell damage.